This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Shanghai Leado Pharmatech Co. Ltd., Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.. Active years: 2025-2026.
Company Filing History:
2 out of 3 
1 out of 15 Years Active: 2025-2026
Title: The Innovations of Qiang Ding
Introduction
Qiang Ding is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical compounds, particularly those targeting transient receptor potential (TRP) channels. With a total of 2 patents, his work has the potential to impact the treatment of various diseases associated with these channels.
Latest Patents
Qiang Ding's latest patents include a 3-aryloxy-3-five-membered heteroaryl propylamine compound and its crystal form. These patents describe a compound, or a pharmaceutically acceptable salt or prodrug thereof, which exhibits excellent inhibition functions for TRP channel proteins. The compounds have shown promising therapeutic effects for diseases linked to TRP channels. Additionally, the preparation method and crystal form of the 3-aryloxy-3-five-membered heteroaryl propylamine compound have been detailed, highlighting their inhibitory effects and therapeutic potential.
Career Highlights
Throughout his career, Qiang Ding has worked with notable companies such as Shanghai Leado Pharmatech Co. Ltd. and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Qiang Ding has collaborated with several professionals in his field, including Lingling Zhang and Youxin Wang. These collaborations have likely enhanced his research and development efforts.
Conclusion
Qiang Ding's contributions to pharmaceutical innovations, particularly in the area of TRP channel inhibitors, demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic options for patients.